KBP Biosciences
Manufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
116 Village Blvd Ste 210, Princeton, New...Website
www.kbpbiosciences.comRevenue
$24.9 MillionIndustry
About KBP Biosciences
KBP Biosciences is a leading biotechnology research and development organization focused on creating innovative therapies for unmet medical needs, particularly in the areas of hypertension, cardiorenal, and infectious diseases. The company utilizes a proprietary integrated discovery and development platform to efficiently transition new drugs from the laboratory to clinical settings worldwide. With a robust pipeline of clinical and preclinical programs, KBP is dedicated to advancing novel solutions to improve patient outcomes. Their target clients include healthcare providers and patients suffering from chronic conditions requiring effective treatment options.Explore more
KBP Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to KBP Biosciences
Compare insights from companies similar to KBP Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$33.6M
201-500
Public
$1.2B
2003
RM
Rishma MerchantSenior Director and Chief of Staff, Clinical Operations
KBP Biosciences Tech Stack
A closer look at the technologies used by KBP Biosciences
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding KBP Biosciences
Sign Up For FreeTo access detailed company insights
KBP Biosciences is a leading biotechnology research and development organization focused on creating innovative therapies for unmet medical needs, particularly in the areas of hypertension, cardiorenal, and infectious diseases. The company utilizes a proprietary integrated discovery and development platform to efficiently transition new drugs from... Read More
